検索結果 - Jean‐Pierre Bronowicki

結果の絞り込み
  1. 1
    The Challenge of Prognosis and Staging for Hepatocellular Carcinoma

    The Challenge of Prognosis and Staging for Hepatocellular Carcinoma 著者: Jorge A. Marrero, Masatoshi Kudo, Jean-Pierre Bronowicki

    出版事項 2010
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort

    Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort 著者: Xavier Adhoute, Guillaume Pénaranda, Jean‐Pierre Bronowicki, Jean‐Luc Raoul

    出版事項 2014
    全文の入手 全文の入手
    Carta
    お気に入りに追加
    保存先:
  3. 3
    Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases

    Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases 著者: Julien Loubinoux, Jean‐Pierre Bronowicki, Inês A. C. Pereira, Jean-Louis Mougenel, Alain Le Faou

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

    Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study 著者: Shannon Ferrante, Jagpreet Chhatwal, Clifford A. Brass, Antoine C. El Khoury, Fred Poordad, Jean-Pierre Bronowicki, Elamin H. Elbasha

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability

    Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability 著者: Cécile Bastard, Stéphane Audière, Julie Foucquier, Hugo Lorée, Véronique Miette, Jean‐Pierre Bronowicki, Christiane Stern, Cyrielle Caussy, Laurent Sandrin

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin

    Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin 著者: M. Diago, Mitchell L. Shiffman, Jean‐Pierre Bronowicki, Stefan Zeuzem, M. Rodríguez‐Torres, S. Chris Pappas, Andreas Tietz, David R. Nelson

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges

    The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges 著者: Marie Müller, Vincent Haghnejad, Marion Schaefer, Guillaume Gauchotte, Bénédicte Caron, Laurent Peyrin‐Biroulet, Jean-Pierre Bronowicki, Cindy Neuzillet, Anthony Lopez

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  8. 8
    Rate of natural disease progression in patients with chronic hepatitis C

    Rate of natural disease progression in patients with chronic hepatitis C 著者: Jean-Pierre Zarski, J. Mc Hutchison, Jean-Pierre Bronowicki, Nathalie Stürm, Richard Garcia‐Kennedy, Enkelejda Hodaj, Brenda Truta, Teresa L. Wright, Robert G. Gish

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients

    Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients 著者: Jean‐Pierre Bronowicki, Denis Vetter, F Dumas, Karim Boudjéma, Robert Bader, Anne-Marie Weiss, Jean-Jacques Wenger, P Boissel, Marc‐André Bigard, Michel Doffoël

    出版事項 1994
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections

    Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections 著者: Graham R. Foster, Christophe Hézode, Jean‐Pierre Bronowicki, Giampiero Carosi, Ola Weiland, Lieselotte Verlinden, Rolf van Heeswijk, Ben Van Baelen, Gastón Picchio, Maria Beumont

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

    Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France 著者: Jean‐Baptiste Chevaux, Abdelbasset Nani, Abderrahim Oussalah, Véronique Venard, Mouni Bensenane, Arthur Belle, Jean‐Louis Guéant, Marc‐André Bigard, Jean-Pierre Bronowicki, Laurent Peyrin–Biroulet

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

    Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection 著者: Olivier Hermine, François Lefrère, Jean‐Pierre Bronowicki, Xavier Mariette, Katayoun Jondeau, Virginie Eclache-Saudreau, B Delmas, Françoise Valensi, P. Cacoub, Christian Bréchot, Bruno Varet, Xavier Troussard

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

    Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy 著者: Jean‐Pierre Bronowicki, Véronique Venard, C. Botté, Nathalie Monhoven, Isabelle Gastin, Laurence Choné, Hervé Hudziak, Bertrand Rhin, Christophe Delanoë, Alain Lefaou, Marc‐André Bigard, P Gaucher

    出版事項 1997
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients

    Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients 著者: Jean‐Pierre Bronowicki, Catherine Bineau, Pierre Feugier, Olivier Hermine, Nicole Brousse, Frédéric Oberti, Marie-Christine Rousselet, Sébastien Dharancy, Philippe Gaulard, Jean–François Fléjou, Dominique Cazals–Hatem, Eric Labouyrie

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    869b Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-Based Therapy: Results From PROMISE, a Phase III Trial

    869b Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-Based Therapy: Results Fr... 著者: Eric Lawitz, Xavier Forns, Stefan Zeuzem, Edward Gane, Jean‐Pierre Bronowicki, Pietro Andreoné, Andrzej Horban, Ashley Brown, Monika Peeters, Oliver Lenz, Sivi Ouwerkerk‐Mahadevan, Ronald Kalmeijer, Maria Beumont‐Mauviel

    出版事項 2013
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)

    Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+) 著者: Vincent Leroy, Peter Angus, Jean‐Pierre Bronowicki, Gregory J. Dore, Christophe Hézode, Stephen Pianko, Stanislas Pol, Katherine Stuart, Edmund Tse, Fiona McPhee, Rafia Bhore, M.J. Jimenez-Exposito, Alexander Thompson

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3... 著者: Jason Grebely, Stefan Mauss, Ashley Brown, Jean‐Pierre Bronowicki, Massimo Puoti, David Wyles, Macky Natha, Yanni Zhu, Junming Yang, Bruce Kreter, Diana M. Brainard, Chohee Yun, Val Carr, Gregory J. Dore

    出版事項 2016
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy

    Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy 著者: Stella Maris Martínez, Juliette Foucher, Jean-Marc Combis, Sophie Métivier, Maurizia Rossana Brunetto, Dominique Capron, Marc Bourlière, Jean‐Pierre Bronowicki, Thông Dao, M. Maynard-Muet, Damien Lucidarme, Wassil Merrouche, Xavier Forns, Victor de Lédinghen

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B

    A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B 著者: Patrick Marcellin, Herve Momméja-Marin, Stephen L. Sacks, George Lau, D. Séréni, Jean‐Pierre Bronowicki, Brian Conway, Christian Trépo, Robert M. Blum, Byung Chul Yoo, Elsa Mondou, J. Sorbel, A. Lynn Snow, Franck Rousseau, Hyo‐Suk Lee

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

    Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial 著者: Mark S. Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, Tarik Asselah, Jean‐Michel Pawlotsky, Stephen D. Shafran, Stanislas Pol, Stefan Mauss, Dominique Larrey, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Schérer, Gerhard Nehmiz, Gerhard Steinmann, Wulf O. Böcher

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: